English   español  
Please use this identifier to cite or link to this item: http://hdl.handle.net/10261/182924
logo share SHARE logo core CORE   Add this article to your Mendeley library MendeleyBASE

Visualizar otros formatos: MARC | Dublin Core | RDF | ORE | MODS | METS | DIDL
Exportar a otros formatos:

Cellular effects mediated by pathogenic LRRK2: homing in on Rab-mediated processes

AuthorsMadero-Pérez, Jesús; Fdez, E.; Fernández, Belén; Lara Ordonez, Antonio J.; Blanca Ramírez, Marian; Romo Lozano, María; Rivero-Rios, Pilar; Hilfiker, Sabine
Rab protein
leucine-rich repeat kinase
vesicular trafficking
Issue Date8-Feb-2017
PublisherPortland Press
CitationBiochemical Society Transactions
AbstractLeucine-rich repeat kinase 2 (LRRK2) is a key player in the pathogenesis of Parkinson's disease. Mutations in LRRK2 are associated with increased kinase activity that correlates with cytotoxicity, indicating that kinase inhibitors may comprise promising disease-modifying compounds. However, before embarking on such strategies, detailed knowledge of the cellular deficits mediated by pathogenic LRRK2 in the context of defined and pathologically relevant kinase substrates is essential. LRRK2 has been consistently shown to impair various intracellular vesicular trafficking events, and recent studies have shown that LRRK2 can phosphorylate a subset of proteins that are intricately implicated in those processes. In light of these findings, we here review the link between cellular deficits in intracellular trafficking pathways and the LRRK2-mediated phosphorylation of those newly identified substrates.
Publisher version (URL)http://dx.doi.org/10.1042/BST20160392
Appears in Collections:(IPBLN) Artículos
Files in This Item:
File Description SizeFormat 
accesoRestringido.pdfReview article15,35 kBAdobe PDFThumbnail
Show full item record
Review this work

Related articles:

WARNING: Items in Digital.CSIC are protected by copyright, with all rights reserved, unless otherwise indicated.